These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 4181019)
21. [Practical realization of the prevention of Rh immunisation]. Pinon F; Cregut R; Poulain M; Huchet J Gynecol Obstet (Paris); 1969; 68(5):469-78. PubMed ID: 4189000 [No Abstract] [Full Text] [Related]
22. [Prevention of hemolytic disease of the newborn with human anti-RH-D immunoglobulin]. Hollán SR Rev Fr Transfus; 1969 Sep; 12(3):319-39. PubMed ID: 4190597 [No Abstract] [Full Text] [Related]
23. [Present status of the prevention of hemolytic disease of the newborn due to Rh factors incompatibility]. de Sousa JS Rev Port Pediatr Pueric; 1969; 32(3):70-6. PubMed ID: 4185738 [No Abstract] [Full Text] [Related]
24. Rhesus sensitization and abortion. Br Med J; 1969 Oct; 4(5675):61. PubMed ID: 4186270 [No Abstract] [Full Text] [Related]
25. [On the prevention of Rh immunization in Sweden]. Bartsch FK; Bergman PO; Bååthe P; Dahlen-Nilsson I; Hansson LA; Ryttinger LA Bibl Haematol; 1969; 32():135-40. PubMed ID: 4980799 [No Abstract] [Full Text] [Related]
26. Prevention of Rh-haemolytic disease--1969. Med J Aust; 1969 May; 1(20):1035-6. PubMed ID: 4182380 [No Abstract] [Full Text] [Related]
27. [Demonstration and elimination of HbF cells in mothers after the birth of ABO-incompatible children]. Luboldt W Bibl Haematol; 1969; 32():312-8. PubMed ID: 4981567 [No Abstract] [Full Text] [Related]
29. [Prevention of Rhesus-sensitization by intravenous administration of immunoglobulin G anti-D. II. General prevention using low doses of IgG anti-D, adapted to the extent of fetomaternal transfusion]. Börner P; Deicher H; Ghani G; Geldmacher H; Kayser D; Kahnt P; Klang D; Klaus H; Marks V; Nehawandian OA Geburtshilfe Frauenheilkd; 1971 Oct; 31(10):911-23. PubMed ID: 5002413 [No Abstract] [Full Text] [Related]
30. [Protective mechanisms in hemolytic disease of the newborn. (Rhesus system)]. Gonzalez Ramos M Ginecol Obstet Mex; 1966; 21(123):469-75. PubMed ID: 4967226 [No Abstract] [Full Text] [Related]
35. [Problems of Rhesus prophylaxis]. Baumgarten K Med Lab (Stuttg); 1982 Oct; 35(4):115-21. PubMed ID: 6185833 [No Abstract] [Full Text] [Related]
36. [Prevention of anti-Rhesus fetomaternal iso-immunization]. André A; Brocteur J; Bustin J Rev Med Liege; 1971 May; 26(9):302-15. PubMed ID: 4103480 [No Abstract] [Full Text] [Related]
37. The prevention of rhesus disease. Midwife Health Visit Community Nurse; 1979 Aug; 15(8):299. PubMed ID: 89617 [No Abstract] [Full Text] [Related]
38. [Studies on the demonstration of fetal erythrocytes in the maternal blood during the postpartum period]. Cordier P; Madeline P; Guillaumin JP; Jeanney JC; Couzineau P Ann Biol Clin (Paris); 1967; 25(7):903-11. PubMed ID: 4965531 [No Abstract] [Full Text] [Related]
40. [Prevention of hemolytic disease of the newborn by use of anti-rhesus (D) immunoglobulin]. Borst-Eilers E Ned Tijdschr Verloskd Gynaecol; 1969 Oct; 69(5):383-91. PubMed ID: 4186579 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]